Products for Research Use Only
RegisterLogin

Selitrectinib

CAT: 0804-HY-101977-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-101977-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Selitrectinib (LOXO-195) is a next-generation TRK kinase inhibitor, with IC50s of 0.6 nM and TRKA and TRKC, respectively[1].
CAS Number
2097002-61-2
Product Name Alternative
LOXO-195
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/LOXO-195.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
FC1=CN=C(CC[C@H](N2)C)C([C@](CCC3)([H])N3C(C=CN4N=C5)=NC4=C5C2=O)=C1
Molecular Formula
C20H21FN6O
Molecular Weight
380.42
Precautions
H302, H315, H319, H335
References & Citations
[1]Drilon A, et al. A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors. Cancer Discov. 2017 Sep;7 (9) :963-972.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
TrkA; TrkC

Alternative Products

CatalogName
MBS5758331Selitrectinib
A19252-100Selitrectinib 100mg
M28716-01(3aR) -Selitrectinib
A19252-10Selitrectinib 10mg
A19252-1Selitrectinib 1mg
A19252-50Selitrectinib 50mg
A19252-25Selitrectinib 25mg
A19252-5Selitrectinib 5mg
S8636-5mgSelitrectinib (LOXO-195)
A19252-10mM-DSelitrectinib 10mM * 1mL in DMSO

Popular Products